Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Shareholders of Saratov oil refinery plant approved dividends for 2023

6/28/24 KRKN

MD Medical Group acquired RGS-Med clinic

6/28/24 MDMG

Rosdorbank plans FPO

6/27/24 RDRB

Buryatzoloto adjusted RAS for the 1st quarter

6/27/24 BRZL

Shareholders of Mobile TeleSystems approved dividends for 2023

6/27/24 MTSS

Shareholders of Tatneft approved dividends for 2023

6/27/24 TATN

Board of Directors of Bashinformsvyaz recommended that dividends be paid for 2023

6/27/24 BISVP

Shareholders of Rosseti Moscow Region approved dividends for 2023

6/27/24 MSRS

Softline will place an additional share issue for M&A financing

6/27/24 SOFL

Novatek plans to ship Line 2 for Arctic LNG-2 at the end of July

6/27/24 NVTK